Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Beissbarth

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Molecular Cancer|January 6, 2012
Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cellsAmanda B Hummon, Jason J Pitt, Jordi Camps, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
The American Journal of Surgical Pathology|January 4, 2013
Frequency of HER-2 positivity in rectal cancer and prognosisLena-Christin Conradi, Hanna Styczen, Thilo Sprenger, et al.
Genome Biology|October 6, 2009
Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profilingKing-Hwa Ling, Chelsee A Hewitt, Tim Beissbarth, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Molecular Cancer|January 6, 2012
Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cellsAmanda B Hummon, Jason J Pitt, Jordi Camps, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
The American Journal of Surgical Pathology|January 4, 2013
Frequency of HER-2 positivity in rectal cancer and prognosisLena-Christin Conradi, Hanna Styczen, Thilo Sprenger, et al.
Genome Biology|October 6, 2009
Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profilingKing-Hwa Ling, Chelsee A Hewitt, Tim Beissbarth, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Pageof 13